4YL3
Crystal Structures of mPGES-1 Inhibitor Complexes
Summary for 4YL3
Entry DOI | 10.2210/pdb4yl3/pdb |
Related | 4YK5 4YL0 4YL1 |
Descriptor | Prostaglandin E synthase, 5-[4-bromo-2-(2-chloro-6-fluorophenyl)-1H-imidazol-5-yl]-2-{[4-(trifluoromethyl)phenyl]ethynyl}pyridine, GLUTATHIONE, ... (6 entities in total) |
Functional Keywords | inhibitor, inflammation, prostaglandin, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Membrane ; Multi-pass membrane protein : O14684 |
Total number of polymer chains | 1 |
Total formula weight | 18292.78 |
Authors | Luz, J.G.,Antonysamy, S.,Kuklish, S.L.,Fisher, M.J. (deposition date: 2015-03-04, release date: 2015-07-08, Last modification date: 2024-02-28) |
Primary citation | Luz, J.G.,Antonysamy, S.,Kuklish, S.L.,Condon, B.,Lee, M.R.,Allison, D.,Yu, X.P.,Chandrasekhar, S.,Backer, R.,Zhang, A.,Russell, M.,Chang, S.S.,Harvey, A.,Sloan, A.V.,Fisher, M.J. Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem., 58:4727-4737, 2015 Cited by PubMed: 25961169DOI: 10.1021/acs.jmedchem.5b00330 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.41 Å) |
Structure validation
Download full validation report